Open AccessAdolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy
Author(s) -
Sato Ken,
Yamazaki Yuichi,
Kanayama Yuki,
Uehara Daisuke,
Tojima Hiroki,
Suga Takayoshi,
Kakizaki Satoru,
Sohara Naondo,
Horiguchi Norio,
Uraoka Toshio
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5690
Subject(s) - medicine , antiviral therapy , chronic hepatitis , adverse effect , hepatitis c , virology , virus
Three Japanese adolescents with chronic hepatitis C were treated by direct‐acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.